Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020)

Historic Preferred Dividend Payments for Beam Therapeutics (BEAM) over the last 2 years, with Q1 2020 value amounting to $1.3 million.

  • Beam Therapeutics' Preferred Dividend Payments changed N/A to $1.3 million in Q1 2020 from the same period last year, while for Dec 2020 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2020, which is 8995.6% down from last year.
  • As of Q1 2020, Beam Therapeutics' Preferred Dividend Payments stood at $1.3 million.
  • In the past 5 years, Beam Therapeutics' Preferred Dividend Payments registered a high of $3.3 million during Q4 2019, and its lowest value of $1.3 million during Q1 2020.